Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2007 (Vol. 27, No. 18)


  • Important coverage of an important subject
  • Nothing significant
If you’re looking for a science site with a distinctively different angle, LabLit may be what you’re after. Conceived with an aim to demolish misleading stereotypical images of scientists, the site aims to provide “real laboratory culture” and is aimed at both scientists and nonscientists. The name is a bit of a play on words, alluding to realistic literature portrayals of scientists. Perusing the offerings at the site, I discovered that the list of recommendations is not restricted to printed media, but also includes plays and even TV shows. The site’s archives contain original works divided into 15 categories, including humor, essay, editorial, poetry, profile, and fiction, to name a few. The site’s creator, Dr. Jennifer Rohn, welcomes contributions from readers and I heartily recommend aiding the effort. A great idea that scientists should embrace. You have nothing to lose but your lab jackets.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »